AtriCure (ATRC) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $45.87 +2.46%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.22), in-line with the analyst estimate of ($0.22). Revenue for the quarter came in at $49.9 million versus the consensus estimate of $48.13 million.
GUIDANCE:
AtriCure sees FY2018 EPS of ($0.69)-($0.74), versus the consensus of ($0.69). AtriCure sees FY2018 revenue of $198-201 million, versus the consensus of $197.91 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
